MELINDA GARRETT: Open Payments
NPI 1134101942 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,147 in 60 payments from 11 companies in 2025. Trend: 2023 $720 · 2024 $866 · 2025 $1,147
Food & beverage: $1,078Education: $69
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 19 | $326 |
| Novartis Pharmaceuticals Corporation | 11 | $235 |
| Regeneron Healthcare Solutions, Inc. | 9 | $165 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $136 |
| UCB, Inc. | 4 | $82 |
| Organon LLC | 4 | $59 |
| Arcutis Biotherapeutics, Inc. | 3 | $48 |
| LEO Pharma Inc. | 2 | $43 |
| ABBVIE INC. | 1 | $24 |
| Galderma Laboratories, L.P. | 1 | $16 |
Products named: TREMFYA, DUPIXENT, COSENTYX, Bimzelx, Rhapsido, ILUMYA, Zoryve, Odomzo.
Industry payments across KY — which companies pay providers there.
